CMO Therapeutics
Enabling global patient access to radiopharmaceutical therapies with proven clinical and commercial capabilities, already serving over 30 countries under the highest quality standards
Manufacturing therapeutic radiopharmaceuticals is supported by an experienced team of over 150 employees dedicated to therapeutics and a state-of-the-art infrastructure to deliver seamless commercial launch at scale, always prioritizing quality.
PharmaLogic’s technical teams bring decades of expertise in manufacturing alpha therapies for over 30 countries, including the U.S., Canada, Europe and Asia. Our extensive expertise in radiochemistry, process development and validation, and automated scale-up of radiopharmaceutical manufacturing enables us to de-risk commercial launches and drive scale and efficiencies. As therapeutic radiopharmaceuticals advance toward regulatory maturity, we provide the already qualifying commercial infrastructure and operational expertise to support clinical and commercial supply.
Partnership Offerings
Why Us?
